Stock listing

NASDAQ:BLUE Bluebird bio Inc Stock

Follow Bluebird bio Inc into a list and get an email when it puts out news.

Last close · NASDAQ:BLUE

$4.97 USD

Close on May 30, 2025 · No longer trades

Dec 13, 2024 to last close -21.6% · daily closes, Dec 13, 2024 – May 30, 2025
Lowest – highest close
$3.29 – $9.92 USDSince Dec 13, 2024 · lowest May 12, 2025 · highest Jan 6, 2025

Delisted NASDAQ:BLUE no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:BLUE
Asset type
Stock
Exchange
NASDAQ
Currency
USD

Bluebird bio Inc on 6ix

Calls
9 calls with a replay · 9 with a transcript · latest Nov 14, 2024
Decks
27 decks · latest Jan 8, 2024

Events

CallWhenStatus
Bluebird bio (BLUE) Q3 2024 Earnings CallThu, Nov 14, 2024 · 8:00 AM ETReplay
Bluebird bio (BLUE) Q2 2024 Earnings CallWed, Aug 14, 2024 · 8:00 AM ETReplay
Bluebird bio (BLUE) Q1 2024 Earnings CallThu, May 09, 2024 · 8:00 AM ETReplay
Bluebird bio (BLUE) Q4 2023 Earnings CallTue, Mar 26, 2024 · 8:00 AM ETReplay
Bluebird bio (BLUE) Q3 2023 Earnings CallTue, Nov 07, 2023 · 8:00 AM ETReplay
Bluebird bio (BLUE) Q2 2023 Earnings CallTue, Aug 08, 2023 · 8:00 AM ETReplay
Bluebird bio (BLUE) Q4 2022 Earnings CallWed, Mar 29, 2023 · 8:00 AM ETReplay
Bluebird bio (BLUE) Q1 2022 Earnings CallTue, Apr 05, 2022 · 8:00 AM ETReplay
Bluebird bio (BLUE) Q2 2021 Earnings CallMon, Aug 09, 2021 · 8:00 AM ETReplay

Open Events

Decks

DeckKindSlidesDate
J.P. Morgan Healthcare Conference 2024Conference23 slidesJan 8, 2024
Corporate Update (December 2023)Corporate update17 slidesDec 11, 2023
Q2 2023 Earnings PresentationEarnings16 slidesAug 8, 2023
Investor Presentation (July 2023)Investor deck27 slidesJul 12, 2023
Investor Presentation (June 2023)Investor deck27 slidesJun 12, 2023
J.P. Morgan Healthcare Conference 2023Conference29 slidesJan 9, 2023
Conference Presentation (January 2021)Conference27 slidesJan 11, 2021
ASH 2019Conference38 slidesDec 10, 2019
EHA Data Review & ZYNTEGLO Approval Webcast (June 2019)Conference38 slidesJun 14, 2019
39th Annual Cowen Healthcare Conference 2019Conference10 slidesMar 12, 2019
All 27 decks
DeckKindSlidesDate
37th Annual J.P. Morgan Healthcare Conference (January 2019)Conference31 slidesJan 9, 2019
Investor Presentation (January 2019)Investor deck74 slidesJan 7, 2019
ASH 2018Conference55 slidesDec 4, 2018
EHA Analyst & Investor Webcast 2018Conference29 slidesJun 15, 2018
ASCO Analyst & Investor Webcast 2018Conference20 slidesJun 4, 2018
36th Annual J.P. Morgan Healthcare Conference (January 2018)Conference22 slidesJan 8, 2018
Investor Presentation (December 2017)Investor deck5 slidesDec 11, 2017
EHA 2017Conference40 slidesJun 23, 2017
Investor Day (June 2017)Investor day35 slidesJun 5, 2017
Investor Presentation (January 2017)Investor deck55 slidesJan 9, 2017
EORTC-NCI-AACR Molecular Targets and Cancer Therapies Symposium 2016Conference22 slidesDec 1, 2016
American Academy of Neurology Annual Meeting 2016Conference22 slidesApr 20, 2016
Investor Presentation (January 2016)Investor deck47 slidesJan 11, 2016
Investor Day (December 2015)Investor day73 slidesDec 7, 2015
EHA 2015Conference22 slidesJun 15, 2015
Investor Presentation (December 2014)Investor deck24 slidesDec 10, 2014
European Hematology Association (EHA) Congress 2014Conference26 slidesJun 16, 2014

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Wendy L Dixon
Other companies: Zevra Therapeutics, Inc. (Director · Since at least Apr 25, 2023); Iovance Biotherapeutics, Inc. (Director · Jun 10, 2022 – Jun 10, 2022 · Past); Black Diamond Therapeutics, Inc. (Director · Apr 6, 2022 – Mar 15, 2024 · Past); Arvinas, Inc. (Director · Jun 29, 2020 – Jun 15, 2023 · Past); Sesen Bio Inc (Director · Jun 12, 2018 – Jun 19, 2019 · Past); Voyager Therapeutics, Inc. (Director · Jan 1, 2017 – Jun 4, 2020 · Past); Eleven Biotherapeutics Inc (Director · Oct 22, 2014 – May 19, 2017 · Past); Ardea Biosciences Inc (Director · Apr 6, 2011 – Jun 19, 2012 · Past); Alkermes plc (Director · Jan 13, 2011 – Jun 14, 2022 · Past); Furiex Pharmaceuticals Inc (Director · May 27, 2010 – Jul 2, 2014 · Past); Incyte Corporation (Director · May 21, 2010 – Mar 31, 2022 · Past); Orexigen Therapeutics Inc (Director · Apr 20, 2010 – Jun 9, 2015 · Past); Dentsply Sirona Inc. (Director · Jul 31, 2007 – Jul 8, 2010 · Past); Bristol-Myers Squibb Company (CMO & Pres, Global Marketing · Mar 7, 2006 – May 22, 2006 · Past)
Director · Jun 18, 2013 – Nov 11, 2021 · Past
Daniel Lynch
Other companies: TCGX Acquisition Corp. (Chairman of the TriGemX Bio Board of Directors · Since Nov 9, 2026); SpringWorks Therapeutics Inc (Director · Since at least Sep 12, 2019); Xilio Therapeutics, Inc. (Director · Oct 21, 2021 – Oct 21, 2021 · Past); 2Seventy Bio Inc (Director · Oct 18, 2021 – Jun 13, 2023 · Past); Omega Alpha SPAC (Director · Jan 6, 2021 – Jan 6, 2021 · Past); Translate Bio Inc (Director · Jun 27, 2018 – Dec 31, 2020 · Past); Sesen Bio Inc (Director · Jun 12, 2018 – Jun 19, 2019 · Past); Surface Oncology Inc (Director · Apr 18, 2018 – Jun 10, 2020 · Past); Blueprint Medicines Corp (Director · Apr 30, 2015 – Jun 24, 2020 · Past); Eleven Biotherapeutics Inc (Director · Feb 5, 2014 – May 19, 2017 · Past); BIND Therapeutics Inc (Director · Sep 19, 2013 – Jun 9, 2015 · Past)
Director · Jun 18, 2013 – Nov 11, 2021 · Past
John M. Maraganore
Other companies: City Therapeutics, Inc. (Executive Chair · Since at least Oct 19, 2026); Takeda Pharmaceutical Co. Ltd. (Director · Since at least Mar 18, 2026); Hemab Therapeutics Holdings, Inc. (Director · Since at least Jan 29, 2026); Rapport Therapeutics, Inc. (Venture Partner, ARCH Venture Partners and Atlas Ventures · Since at least Jun 6, 2024); Kymera Therapeutics, Inc. (Director · Since at least Jan 17, 2022); Beam Therapeutics Inc. (Board Member · Since at least Nov 5, 2021); Alnylam Pharmaceuticals, Inc. (Director · Since at least May 12, 2006); Instil Bio, Inc. (Director · Jun 11, 2025 – Nov 4, 2026 · Past); ProKidney Corp. (Director · Jul 11, 2022 – Jun 29, 2023 · Past); Agios Pharmaceuticals, Inc. (Director · Jul 23, 2013 – Dec 31, 2022 · Past); Regulus Therapeutics Inc (Director · Oct 4, 2012 – Oct 10, 2012 · Past)
Director · Jun 18, 2013 – Sep 14, 2017 · Past
Mary Lynne Hedley
Other companies: Eli Lilly and Company (Director · Since at least May 15, 2022); Centessa Pharmaceuticals PLC (Director · Since at least May 27, 2021); Veeva Systems Inc. (Director · Since at least Aug 16, 2019); Tempest Therapeutics, Inc. (Director · Dec 7, 2018 – Jun 22, 2020 · Past); Receptos Inc (Director · Apr 11, 2014 – Aug 27, 2015 · Past); Tesaro Inc (President & COO, Director · Jun 27, 2012 – Jan 22, 2019 · Past); Abraxis BioScience Inc (Executive VP of Ops & CSO · Jul 9, 2009 – Jul 13, 2009 · Past)
Director · Sep 18, 2017 – Jun 20, 2018 · Past
David Schenkein
Other companies: Regeneron Pharmaceuticals, Inc. (Director · Since at least Sep 8, 2023); Prime Medicine, Inc. (Board Member · Since at least Oct 19, 2022); Denali Therapeutics Inc. (Director · Since at least Dec 7, 2017); Foundation Medicine Inc (Director · Sep 24, 2013 – Jun 16, 2016 · Past); Agios Pharmaceuticals, Inc. (Director · Jul 23, 2013 – Jun 20, 2024 · Past); Foghorn Therapeutics Inc. (General Partner, Co-leader, Agios · Until Apr 13, 2026 · Past)
Director · Jun 18, 2013 – Jun 18, 2020 · Past
Denice Torres
Other companies: Seaport Therapeutics, Inc. (Board Member · Since at least Apr 30, 2026); Celldex Therapeutics, Inc. (Chief Executive Officer; The Ignited Company · Since at least Jun 5, 2025); Glaukos Corporation (Director · Since at least Mar 1, 2021); 2Seventy Bio Inc (Director · Oct 18, 2021 – May 13, 2025 · Past); Surface Oncology Inc (Director · Jul 6, 2021 – Jun 8, 2022 · Past); Karuna Therapeutics Inc (Director · Dec 22, 2020 – Mar 18, 2024 · Past)
Director · Aug 10, 2020 – Nov 11, 2021 · Past
Linda Bain
Other companies: Hemab Therapeutics Holdings, Inc. (Director · Since at least Apr 30, 2026); Autolus Therapeutics plc (Chair of the Audit Committee, Member of the Nominating and Governance Committee · Since at least Mar 18, 2026); Arvinas, Inc. (Director · Since at least Jun 10, 2020); VBI Vaccines Inc. (Director · Jul 1, 2021 – Jan 27, 2022 · Past); Codiak BioSciences Inc (Chief Financial Officer · Oct 13, 2020 – Mar 28, 2023 · Past); Adverum Biotechnologies Inc (Chief Financial Officer · Jul 30, 2014 – Aug 21, 2015 · Past)
VP, Fin. & Business Operations · Jun 18, 2013 – Feb 26, 2014 · Past
Robert I Tepper
Other companies: Constellation Pharmaceuticals Inc (Director · Jul 18, 2018 – Jun 6, 2019 · Past); Allena Pharmaceuticals Inc (Director · Nov 1, 2017 – Jun 5, 2019 · Past); Kala Bio, Inc. (Director · Jul 19, 2017 – Jul 25, 2017 · Past); Jounce Therapeutics Inc (Director · Jan 26, 2017 – Jun 26, 2020 · Past); Dare Bioscience, Inc. (Director · Apr 10, 2014 – Jun 26, 2015 · Past); Millennium Pharmaceuticals Inc (President, R&D · Sep 15, 2005 – Feb 12, 2007 · Past)
Director · Jun 18, 2013 – Feb 3, 2015 · Past
Mitchell H Finer
Other companies: PepGen Inc. (Director · Since at least Mar 27, 2025); Turmeric Acquisition Corp (Director · Oct 15, 2020 – Oct 15, 2020 · Past); Oncorus Inc (Director · Oct 1, 2020 – Jun 23, 2022 · Past); Tcr2 Therapeutics Inc (Director · Feb 13, 2019 – Feb 13, 2019 · Past); Adverum Biotechnologies Inc (Director · May 11, 2016 – Jul 31, 2019 · Past)
Chief Scientific Officer · Jun 18, 2013 – Jun 1, 2015 · Past
John Agwunobi
Other companies: The Ensign Group, Inc. (Director · Since at least Jan 1, 2023); Herbalife Ltd. (Chairman and CEO, Director · May 1, 2018 – May 10, 2022 · Past); Magellan Health Inc (Director · Dec 10, 2014 – May 24, 2018 · Past)
Director · Since at least Jun 8, 2017
All 42 people
PersonSeat
Joseph Vittiglio
Other companies: PepGen Inc. (Chief Business and Legal Officer · Since at least Dec 8, 2025); AMAG Pharmaceuticals Inc (Chief Business Officer, GC · Aug 24, 2015 – Nov 16, 2020 · Past); AVEO Pharmaceuticals Inc (SVP, General Counsel · May 30, 2012 – Jan 6, 2015 · Past)
Chief Business & Legal Officer · Since at least Jan 3, 2023
William D Baird III
Other companies: 2Seventy Bio Inc (President and CEO, Director · Oct 18, 2021 – May 13, 2025 · Past); Axcella Health Inc (Director · May 8, 2019 – May 19, 2022 · Past); Amicus Therapeutics Inc (Chief Financial Officer · Apr 16, 2012 – Oct 15, 2018 · Past)
Chief Financial Officer · Feb 11, 2019 – Nov 11, 2021 · Past
Alison C. Finger
Other companies: ADMA Biologics Inc (Director · Since at least Sep 28, 2023); Decibel Therapeutics Inc (Director · Dec 3, 2021 – Sep 25, 2023 · Past)
Chief Commercial Officer · Feb 14, 2018 – Jan 5, 2021 · Past
Elisabeth Leiderman
Other companies: Autolus Therapeutics plc (Director · Since at least Mar 18, 2026); Decibel Therapeutics Inc (Chief Financial Officer · Feb 11, 2021 – Feb 25, 2022 · Past)
Director · Since at least Oct 15, 2021
Jim DeTore
Other companies: CG Oncology, Inc. (Chief Financial Officer · Since at least Nov 17, 2025); Kineta Inc. (See Remarks · Aug 4, 2016 – Aug 4, 2016 · Past)
Chief Financial Officer · Nov 10, 2014 – Dec 1, 2014 · Past
Michael Cloonan
Other companies: Sionna Therapeutics, Inc. (President & CEO, Director · Since at least Feb 6, 2025); Sage Therapeutics Inc (Chief Business Officer · Apr 2, 2018 – Feb 10, 2021 · Past)
Director · Since at least Jun 20, 2024
Nick Leschly
Other companies: 2Seventy Bio Inc (Director · Oct 18, 2021 – May 13, 2025 · Past); Synlogic Inc (Director · Jun 10, 2021 – Jun 22, 2023 · Past)
Director · Since at least Oct 2, 2020
Philip D Gregory
Other companies: 2Seventy Bio Inc (Chief Scientific Officer · Nov 4, 2021 – Jan 5, 2024 · Past); Sangamo Therapeutics, Inc. (SVP of Research & CSO · Dec 12, 2005 – Jun 1, 2015 · Past)
Chief Scientific Officer · Jun 15, 2015 – Nov 11, 2021 · Past
Anne-Virginie Eggimann
Other companies: Codiak BioSciences Inc (Director · May 17, 2021 – Jun 17, 2022 · Past)
Chief Regulatory Officer · Jan 11, 2022 – Jul 12, 2022 · Past
Christopher Krawtschuk
Other companies: Eagle Pharmaceuticals, Inc. (Chief Financial Officer · Since at least Nov 11, 2024)
Chief Financial Officer · Nov 7, 2022 – Mar 1, 2024 · Past
Eric Sullivan
Other companies: Tcr2 Therapeutics Inc (Chief Financial Officer · Jun 27, 2022 – Jun 1, 2023 · Past)
Principal Accounting Officer · Mar 7, 2014 – Aug 3, 2017 · Past
Jason Cole
Other companies: EPIRUS Biopharmaceuticals Inc (EVP,Corp Dev & General Counsel · Jan 23, 2006 – Jan 3, 2013 · Past)
Chief Strategy & Financial Off · Mar 7, 2014 – Aug 19, 2022 · Past
Jeffrey T. Walsh
Other companies: Tenaya Therapeutics, Inc. (Board Member · Since at least Jul 29, 2021)
Chief Strategy Officer · Mar 11, 2019 – Aug 20, 2019 · Past
Kory Wentworth
Other companies: Entrada Therapeutics, Inc. (Chief Financial Officer · Since at least Oct 28, 2021)
Principal Accounting Officer · Dec 18, 2017 – Aug 3, 2020 · Past
Marcela V Maus
Other companies: 2Seventy Bio Inc (Director · Oct 18, 2021 – May 13, 2025 · Past)
Director · Sep 7, 2021 – Nov 11, 2021 · Past
O James Sterling
Other companies: Renalytix PLC (Chief Financial Officer · Jul 1, 2023 – Jul 6, 2023 · Past)
Chief Financial Officer · Since at least Jun 10, 2024
Richard Paulson
Other companies: Karyopharm Therapeutics Inc. (President and Chief Executive Officer · Since at least Feb 26, 2020)
Director · Since at least Apr 3, 2023
Susanna Gatti High
Other companies: Dyne Therapeutics, Inc. (Chief Operating Officer · Sep 16, 2020 – Sep 18, 2024 · Past)
Chief Operating Officer · Dec 1, 2016 – Dec 6, 2018 · Past
William R Sellers
Other companies: 2Seventy Bio Inc (Director · Oct 18, 2021 – Nov 11, 2021 · Past)
Director · Sep 25, 2019 – Nov 11, 2021 · Past
Andrew ObenshainPresident and CEO, Director · Since at least Nov 3, 2023
Charlotte Jones-BurtonDirector · Since at least Mar 7, 2022
David DavidsonChief Medical Officer · Jun 18, 2013 – Apr 5, 2021 · Past
Douglas MeltonDirector · Jun 6, 2019 – Jun 18, 2020 · Past
Geert-Jan MulderDirector · Jun 18, 2013 – Jun 24, 2013 · Past
James MandellDirector · Jan 8, 2014 – Sep 10, 2018 · Past
Jessica WhittenChief Accounting Officer · Nov 4, 2021 – Feb 1, 2022 · Past
Joanne Smith-FarrellCOO, Oncology · Jan 6, 2020 – Jan 5, 2021 · Past
Katy BurnettPrincipal Accounting Officer · Sep 8, 2020 – Feb 16, 2021 · Past
Mark VachonDirector · Since at least Nov 6, 2024
Najoh Tita-ReidDirector · Since at least Jun 22, 2022
Richard A ColvinChief Medical Officer · Since at least Aug 22, 2022
Thomas J KlimaSee Remarks · Since at least May 10, 2021

Open People

Log in to ask 6ix AI your own questions about Bluebird bio Inc.